These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2947996)

  • 21. Suppression of murine lymphocyte mitogen responses by exopolysaccharide from Capnocytophaga ochracea.
    Bolton RW; Dyer JK
    Infect Immun; 1983 Jan; 39(1):476-9. PubMed ID: 6822434
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complement activation in systemic sclerosis.
    Wild G; Watkins J; Ward AM; Hughes P; Hume A; Rowell NR
    J Clin Lab Immunol; 1990 Jan; 31(1):39-41. PubMed ID: 1966983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anaphylatoxin levels in human aqueous humor.
    Mondino BJ; Sumner H
    Invest Ophthalmol Vis Sci; 1986 Aug; 27(8):1288-92. PubMed ID: 3488296
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Purification and chemical characterization of an exopolysaccharide isolated from Capnocytophaga ochracea.
    Dyer JK; Bolton RW
    Can J Microbiol; 1985 Jan; 31(1):1-5. PubMed ID: 3986710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activated complement in inflamed aqueous humor.
    Mondino BJ; Glovsky MM; Ghekiere L
    Invest Ophthalmol Vis Sci; 1984 Jul; 25(7):871-3. PubMed ID: 6610667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a simple radioimmunoassay for human C3a.
    Lamche HR; Paul E; Schlag G; Redl H; Hammerschmidt DE
    Inflammation; 1988 Jun; 12(3):265-76. PubMed ID: 3262087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Physiological and pathological effects of activated complement.
    Dierich MP; Schulz T
    Haematologia (Budap); 1984; 17(1):3-16. PubMed ID: 6373514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Measurement of plasma C3a and C5a in patients with various lung diseases and rabbits with endotoxin shock].
    Kinoshita M; Uetsuka N; Wagai F; Watanabe H; Uchida Y; Kitamura S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1986 Feb; 24(2):145-9. PubMed ID: 3488459
    [No Abstract]   [Full Text] [Related]  

  • 29. C3, C5 components and C3a, C4a, and C5a fragments of the complement system.
    Janatova J
    Methods Enzymol; 1988; 162():579-625. PubMed ID: 3265757
    [No Abstract]   [Full Text] [Related]  

  • 30. Interaction of prostaglandins, activated complement, and granulocytes in clinical sepsis and hypotension.
    Slotman GJ; Burchard KW; Williams JJ; D'Arezzo A; Yellin SA
    Surgery; 1986 Jun; 99(6):744-51. PubMed ID: 3520916
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A dominant complement fixation pathway for pneumococcal polysaccharides initiated by SIGN-R1 interacting with C1q.
    Kang YS; Do Y; Lee HK; Park SH; Cheong C; Lynch RM; Loeffler JM; Steinman RM; Park CG
    Cell; 2006 Apr; 125(1):47-58. PubMed ID: 16615889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of iodinated contrast media on a radioimmunoassay of C3a.
    Eaton S; Tsay HM; Yost F; Tweedle M
    Clin Chem; 1987 Aug; 33(8):1470. PubMed ID: 3496991
    [No Abstract]   [Full Text] [Related]  

  • 33. A modified competitive inhibition radioimmunoassay for the detection of C3a. Use of 125I-C3 instead of 125I-C3a.
    Hack CE; Paardekooper J; Eerenberg AJ; Navis GO; Nijsten MW; Thijs LG; Nuijens JH
    J Immunol Methods; 1988 Apr; 108(1-2):77-84. PubMed ID: 3258341
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complement activation in type 1 human diabetes.
    Sundsmo JS; Papin RA; Wood L; Hirani S; Waldeck N; Buckingham B; Kershnar A; Ascher M; Charles MA
    Clin Immunol Immunopathol; 1985 May; 35(2):211-25. PubMed ID: 3907907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro inhibition of the classical and alternate pathways of activation of human complement by N acetyl aspartyl glutamic acid (NAAGA).
    Etievant M; Leluc B; David B
    Agents Actions; 1988 Jun; 24(1-2):137-44. PubMed ID: 3261498
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of the alternative complement pathway by intraocular lenses.
    Mondino BJ; Nagata S; Glovsky MM
    Invest Ophthalmol Vis Sci; 1985 Jun; 26(6):905-8. PubMed ID: 4008203
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complement system is not activated in primary biliary cirrhosis.
    Gardinali M; Conciato L; Cafaro C; Crosignani A; Battezzati PM; Agostoni A; Podda M
    Clin Immunol Immunopathol; 1998 Jun; 87(3):297-303. PubMed ID: 9646840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Activation mechanism and reaction process of the complement system--the classical pathway].
    Sakai K; Yasuda M; Tomooka K; Nobunaga M
    Nihon Rinsho; 1979 May; 37(5):943-55. PubMed ID: 381725
    [No Abstract]   [Full Text] [Related]  

  • 39. Classical complement pathway in HIV infection.
    Senaldi G; Peakman M; McManus T; Davies ET; Tee DE; Vergani D
    Lancet; 1989 Sep; 2(8663):624. PubMed ID: 2570318
    [No Abstract]   [Full Text] [Related]  

  • 40. Elevated plasma levels of the anaphylatoxins C3a and C4a are associated with a fatal outcome in sepsis.
    Hack CE; Nuijens JH; Felt-Bersma RJ; Schreuder WO; Eerenberg-Belmer AJ; Paardekooper J; Bronsveld W; Thijs LG
    Am J Med; 1989 Jan; 86(1):20-6. PubMed ID: 2783358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.